Koniflam Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Meloxicam

Indications/Uses

Short-term symptomatic therapy of acute exacerbation of OA, long-term symptomatic therapy of RA (chronic polyarthritis).

Dosage/Direction for Use

RA 15 mg daily, may be reduced to 7.5 mg/day. OA 7.5 mg daily, may be increased to 15 mg/day. Max: 15 mg/day. Dialysis patient w/ severe kidney failure Max: 7.5 mg/day.

Administration

May be taken with or without food: May be taken w/ meals if GI discomfort occurs.

Contraindications

Hypersensitivity. Patients w/ salicylic acid or other NSAIDs-induced asthma, nasal polyp, angioedema or urticaria. Active or recent GI ulceration or perforation, severe liver & non-dialysis kidney insufficiency, active bowel inflammatory disease, uncontrolled severe heart failure. Pregnancy & lactation. Childn & adolescent <15 yr.

Special Precautions

Patients w/ HTN, fluid retention or heart failure. History of peptic ulcer &/or GI bleeding.

Adverse Reactions

Anemia, headache, dizziness, drowsiness, increased BP, palpitation, heart failure, dyspepsia, nausea, vomiting, abdominal pain.

View ADR Reporting Link

Drug Interactions

Prostaglandin synthetase inhibitor including salicylate & glucocorticoid in high dose, oral anticoagulant, lithium, MTX, contraceptive agents, diuretics, antihypertensive drugs.

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

ATC Classification

M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, oxicams.

Regulatory Classification

Presentation/Packing

Form

Koniflam tab 15 mg

Packing/Price

3 × 10's

Koniflam

meloxicam

Manufacturer:

Konimex

Marketer:

Konimex